1999
DOI: 10.7164/antibiotics.52.374
|View full text |Cite
|
Sign up to set email alerts
|

Feglymycin, a Novel Inhibitor of the Replication of the Human Immunodeficiency Virus. Fermentation, Isolation and Structure Elucidation.

Abstract: The novel peptide feglymycin has been isolated from cultures of Streptomyces sp. DSM 11171 by solid phase extraction, size exclusion chromatography and repeated reversed-phase chromatography. The molecular weight was found to be 1900.90 g/mol and the molecular formula is C95H97N13O30. Feglymycin contains 13 amino acids of which four are 3-hydroxyphenylglycine and five are 3,5-dihydroxyphenylglycine residues. The

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
25
0
2

Year Published

2000
2000
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 20 publications
0
25
0
2
Order By: Relevance
“…Synthetic 1 (and 1') exhibited identical physical properties (R f , HPLC, 1 H NMR, MS) to those of natural feglymycin. [1,18] For the investigation of biological activity, the natural product and a selection of synthetic intermediates were chosen for antiviral testing (see the Supporting Information for complete data). The anti-HIV-1 activity of the compounds was evaluated in the human MT-4 cell line.…”
Section: Angewandte Chemiementioning
confidence: 99%
See 2 more Smart Citations
“…Synthetic 1 (and 1') exhibited identical physical properties (R f , HPLC, 1 H NMR, MS) to those of natural feglymycin. [1,18] For the investigation of biological activity, the natural product and a selection of synthetic intermediates were chosen for antiviral testing (see the Supporting Information for complete data). The anti-HIV-1 activity of the compounds was evaluated in the human MT-4 cell line.…”
Section: Angewandte Chemiementioning
confidence: 99%
“…DSM 11171, strongly inhibits the formation of HIV syncytia in vitro and was reported to show weak antibacterial activity against Gram-positive bacteria. [1] The molecular structure of 1 was first determined by mass spectrometry and NMR spectroscopy in the mid-1990s and was proven in 2005 by Sheldrick and co-workers by X-ray crystallography. [2] The unusual primary structure of 1 consists of an alternating sequence of mostly aromatic S-and Rconfigured amino acid residues.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Sowohl 1 als auch 1' wiesen identische physikalische Eigenschaften (R f , HPLC, 1 H-NMR, MS) wie natürliches Feglymycin auf. [1,18] Zur Untersuchung der biologischen Aktivität wurden einige synthetische Peptidintermediate zusammen mit dem Naturstoff für antiretrovirale Tests ausgewählt (kompletter Datensatz siehe Hintergrundinformationen). Die Anti-HIV-1-Aktivität dieser Verbindungen wurde in Zellkultur in menschlichen MT-4-Zellen ermittelt.…”
Section: Methodsunclassified
“…Zudem wurde eine schwach antibakterielle Aktivität gegen Grampositive Bakterien beschrieben. [1] Die Struktur von 1 wurde zunächst durch massenspektrometrische Methoden und NMR-Spektroskopie in der Mitte der 90er Jahre aufgeklärt und 2005 nach Lösung der Röntgenkristallstruktur durch Sheldrick et al bestätigt. [2] Die ungewöhnliche Primärsequenz von 1 besteht überwiegend aus einer alternierenden Sequenz aromatischer (S)-und (R)-konfigurierter Aminosäuren.…”
unclassified